Nutra Pharma Files Updated Provisional Patent for Nerve Agent Counter Measures
Nutra Pharma has filed an updated provisional patent for the protection of their intellectual property surrounding the use of RPI-78M and...
Nutra Pharma Engages Government Affairs Consulting Firm
Nutra Pharma is working with Washington DC-based government affairs consultants and lobbyists to support their Nyloxin® line of pain...
Nutra Pharma Announces that Diverse Health Services has Added Nyloxin to Their Product Offerings
Diverse Health Services, an industry leader in Chiropractic care and Alternative Medicine, announced the addition of the Nyloxin® line of...
Nutra Pharma Announces Private Label Expansion of their Over-The-Counter Pain Relievers
Nutra Pharma is announcing the first private label agreement in expansion of their line of over-the-counter pain relievers and...
Professional Snowboarder Jake Vedder Joins Nutra Pharma in Endorsing Nyloxin for Chronic Pain Relief
Nutra Pharma announces that professional snowboarder and wakeboarder, Jake Vedder, is endorsing Nyloxin for Chronic Pain Relief as part...